Annexin Pharmaceuticals AB
SEK6.64
2
-SEK0.06-0.9%Friday 10:26
Statistics
Day High
6.8
Day Low
6.52
52W High
27.8
52W Low
6.52
Volume
7,974
Avg. Volume
9,292
Mkt Cap
11.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
May 24Expected
Q2 2020
Q3 2020
Q1 2024
-0.16
-0.12
-0.08
-0.04
Expected EPS
N/A
Actual EPS
-0.0359
Financials
-Profit Margin
Unprofitable0Revenue
-36.89MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natural protein that protects and repairs cells, as well as counteract unwanted inflammatory and immune cell reactions. Annexin Pharmaceuticals AB (publ) was incorporated in 2014 and is based in Stockholm, Sweden.
Show More
CEO
Nils Anders Haegerstrand
Employees
4
Country
Sweden
ISIN
SE0025159387
WKN
000A419FT
Listings
0 Comments
Share your thoughts
FAQs
What is Annexin Pharmaceuticals AB stock price today?▼
The current price of ANNX.ST is SEK6.64 SEK — it has decreased by -0.9% in the past 24 hours. Watch Annexin Pharmaceuticals AB stock price performance more closely on the chart.
What is Annexin Pharmaceuticals AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Annexin Pharmaceuticals AB stocks are traded under the ticker ANNX.ST.
Is Annexin Pharmaceuticals AB stock price growing?▼
ANNX.ST stock has fallen by -14.21% compared to the previous week, the month change is a -25.56% fall, over the last year Annexin Pharmaceuticals AB has showed a -74.85% decrease.
What is Annexin Pharmaceuticals AB market cap?▼
Today Annexin Pharmaceuticals AB has the market capitalization of 11.02M
What were Annexin Pharmaceuticals AB earnings last quarter?▼
ANNX.ST earnings for the last quarter are -0.04 SEK per share, whereas the estimation was N/A SEK resulting in a N/A surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Annexin Pharmaceuticals AB revenue for the last year?▼
Annexin Pharmaceuticals AB revenue for the last year amounts to 0 SEK.
What is Annexin Pharmaceuticals AB net income for the last year?▼
ANNX.ST net income for the last year is -36.89M SEK.
How many employees does Annexin Pharmaceuticals AB have?▼
As of November 1, 2026, the company has 4 employees.
In which sector is Annexin Pharmaceuticals AB located?▼
Annexin Pharmaceuticals AB operates in the Health & Wellness sector.
When did Annexin Pharmaceuticals AB complete a stock split?▼
The last stock split for Annexin Pharmaceuticals AB was on May 28, 2025 with a ratio of 1:100.
Where is Annexin Pharmaceuticals AB headquartered?▼
Annexin Pharmaceuticals AB is headquartered in Stockholm, Sweden.